A
86.17
1.90 (2.25%)
| Penutupan Terdahulu | 84.27 |
| Buka | 85.00 |
| Jumlah Dagangan | 504,936 |
| Purata Dagangan (3B) | 476,595 |
| Modal Pasaran | 4,632,128,512 |
| Harga / Jualan (P/S) | 25.36 |
| Harga / Buku (P/B) | 8.47 |
| Julat 52 Minggu |
| Margin Keuntungan | -25.94% |
| Margin Operasi (TTM) | -129.14% |
| EPS Cair (TTM) | -0.710 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 74.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 13.53% |
| Nisbah Semasa (MRQ) | 4.29 |
| Aliran Tunai Operasi (OCF TTM) | 20.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 37.50 M |
| Pulangan Atas Aset (ROA TTM) | -6.29% |
| Pulangan Atas Ekuiti (ROE TTM) | -10.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Arcellx, Inc. | Menaik | Menaik |
AISkor Stockmoo
1.1
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.13 |
|
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 12.62% |
| % Dimiliki oleh Institusi | 94.86% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 136.00 (Truist Securities, 57.83%) | Beli |
| Median | 114.50 (32.88%) | |
| Rendah | 100.00 (B of A Securities, 16.05%) | Beli |
| Purata | 113.40 (31.60%) | |
| Jumlah | 10 Beli | |
| Harga Purata @ Panggilan | 92.14 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 10 Dec 2024 | 115.00 (33.46%) | Beli | 82.27 |
| 08 Nov 2024 | 115.00 (33.46%) | Beli | 103.06 | |
| Needham | 10 Dec 2024 | 105.00 (21.85%) | Beli | 82.27 |
| 09 Dec 2024 | 105.00 (21.85%) | Beli | 82.95 | |
| UBS | 10 Dec 2024 | 114.00 (32.30%) | Beli | 82.27 |
| Truist Securities | 12 Nov 2024 | 136.00 (57.83%) | Beli | 100.48 |
| Piper Sandler | 08 Nov 2024 | 115.00 (33.46%) | Beli | 103.06 |
| B of A Securities | 06 Nov 2024 | 100.00 (16.05%) | Beli | 92.98 |
| Baird | 06 Nov 2024 | 106.00 (23.01%) | Beli | 92.98 |
| Morgan Stanley | 06 Nov 2024 | 106.00 (23.01%) | Beli | 92.98 |
| Stifel | 18 Oct 2024 | 122.00 (41.58%) | Beli | 96.86 |
| Canaccord Genuity | 17 Oct 2024 | 115.00 (33.46%) | Beli | 95.27 |
| Papar semua | ||||
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |